Fundraising FoxBluebird Ventures — Full Portfolio
14 tracked investments · listed companies and verified rows first
GRAIL develops the Galleri blood test for multi-cancer early detection using next-generation sequencing and machine learning to screen for multiple deadly cancer types before symptoms appear.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesMenlo Park, US
Jeffrey T. Huber(Director)Joshua Ofman, MD, MSHS(Chief Executive Officer)inAaron Freidin(Executive Officer)inRobert Ragusa(Executive Officer, Director)Jennifer Cook(Executive Officer, Director)inRichard Klausner(Director)
PartnerJeffrey Bird· solo GP
Co-investorsAmino CapitalARCH Venture PartnersBezos ExpeditionsDecheng CapitalDentsu VenturesFelicis Ventures+13 more
-2.png)
Leyden Labs develops nasal sprays containing antibodies that target respiratory viruses such as influenza and COVID at the nasal mucosa to prevent initial infection and transmission.
BiotechDeep TechHealthtechLeiden, NL
Koenraad Wiedhaup(Founder & Chief Executive Officer)inRonald Brus(Founder & Chief Growth Officer)inJaap Goudsmit(Founding Scientist and Senior Advisor)inDinko Valerio(Founder and Chair of the Supervisory Board)inJintanat Ananworanich(Chief Medical Officer)inClarissa Koch(Chief Scientific Officer)in
Co-investorsClavystBioF-Prime CapitalGV (Google Ventures)Byers CapitalCasdin CapitalEuropean Innovation Council Fund+7 more
Epirium Bio develops novel oral therapeutics targeting mitochondrial dysfunction and muscle diseases, particularly muscular dystrophy.
BiotechMedical DevicesSan Diego, US
Pam Taub(M.D., FACC, Founder)Alan Maisel(M.D., Founder)Francisco Villarreal(M.D., Ph.D., Founder)Jonathan Taub(Co-founder and first Chief Executive Officer)Guillermo Ceballos(M.D., Founding Scientist)Pam Taub, M.D., FACC(Co-founder)
PartnerJeffrey Bird· solo GP
Co-investorsBroadview VenturesLongitude CapitalAdams Street PartnersARCH Venture PartnersVertex VenturesVertex Ventures HC
Gilead discovers, develops, and delivers therapeutic medicines for life-threatening diseases, with focus on virology, oncology, and inflammation across 35+ countries.
BiotechHealthtechMedical DevicesPalo Alto, US
Ravindra Majeti(Director)Irving Weissman(Director)Eric Jensen(Executive Officer)
BoardChristopher Schaepe(Director)inJeffrey Bird(Director)Dennis Henner(Director)
PartnerJeffrey Bird· solo GP
Co-investorsGV (Google Ventures)Lightspeed Venture PartnersSofinnova VenturesClarus VenturesSutter Hill VenturesWellington Management
Kriya provides working capital loans and business finance products to UK and European businesses, helping them manage cash flow, fund wholesale orders, and scale their buyer base.
FintechSaaS
Anil Stocker(Founder)inCharles Delingpole(Founder)Ilya Kondrashov(Founder)
Co-investorsMouro CapitalNorthzoneForesite CapitalHolland CapitalJDRF T1D FundNarya Capital+3 more
Kriya Therapeutics is a biopharmaceutical company that develops and manufactures one-time gene therapies aimed at treating prevalent chronic diseases.
BiotechHealthtechMorrisville, US
Roger Jeffs(Co-Founder and Vice Chairman)inFraser Wright(Scientific Co-Founder and Chief Gene Therapy Officer)inShankar Ramaswamy(Founder)inMichele Stone(Chief Scientific Officer)inKatherine Eade(Chief Legal Officer)Britt Petty(Chief Manufacturing Officer)in
PartnerJeffrey Bird· solo GP
Co-investorsPatient Square CapitalPremji InvestAlumni VenturesAmplo VenturesAnjostForesite Capital+3 more
Medikine engineers cytokine mimetics — peptide-based therapeutics that mimic natural cytokines — to treat serious diseases, with a focus on immuno-oncology.
BiotechHealthtechSan Diego, US
William J. Dower(Co-founder and Scientific Advisor)Michael C. Needels(Co-founder and CTO)Ronald W. Barrett(CEO and Chairman of the Board)Joseph Leveque(CEO, President, and Board Member)in
PartnerJeffrey Bird· solo GP
Co-investorsLightspeed Venture Partners
RNA therapeutics company with a chip-based mRNA manufacturing platform; acquired by Medici Therapeutics in November 2025.
BiotechEmeryville, US
Igor Khandros(Executive Officer, Director)
PartnerJeffrey Bird· solo GP
Co-investors+ND CapitalARCH Venture PartnersByers CapitalCraft VenturesFounders FundParadigm+2 more
Portola develops research and investigates new targets, modalities, and technologies to address rare disease challenges for patients and their families.
BiotechDigital HealthHealthtechMedical Devices
PartnerJeffrey Bird· solo GP
Co-investorsFrazier Life SciencesLightstone VenturesProspect Venture PartnersKhosla VenturesNFDG
Procyrion develops medical devices for circulatory support in heart failure treatment, supported by a team of cardiologists and medical device industry veterans.
BiotechHealthtechMedical DevicesHouston, US
Reynolds, III M. Delagado(Director)Benjamin A. Hertzog(Executive Officer, Director)Dr. Fain(Founder/Executive)Jason J Heuring(Executive Officer)Bryan E. Nearn(Vice President)
BoardLeo III E Linbeck(Director)
PartnerJeffrey Bird· solo GP
Co-investorsScientific Health DevelopmentTexas VenturesFannin Goldenrod Holdings
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Cardero TherapeuticsHelixTeneobioVerinata Health
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.